Dr. Reddy's Laboratories is currently trading at Rs. 6914.00, up by 19.70 points or 0.29% from its previous closing of Rs. 6894.30 on the BSE.
The scrip opened at Rs. 6885.00 and has touched a high and low of Rs. 6950.00 and Rs. 6868.70 respectively. So far 4107 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 7030.00 on 29-Jul-2024 and a 52 week low of Rs. 5212.10 on 30-Oct-2023.
Last one week high and low of the scrip stood at Rs. 7030.00 and Rs. 6736.60 respectively. The current market cap of the company is Rs. 115273.48 crore.
The promoters holding in the company stood at 26.65%, while Institutions and Non-Institutions held 48.40% and 10.36% respectively.
Dr. Reddy's Laboratories’ wholly-owned subsidiary -- Aurigene Oncology (AOL) (formerly, Aurigene Discovery Technologies) has made an investment of Rs 2.08 crore in Clean Renewable Energy KK 2A (CREL) and CREL has allotted 20,21,600 equity shares of Rs 10 each at a premium of Rs 0.32 per share to AOL on July 31, 2024.
The fund infused by AOL in CREL is to meet the development cost of project in compliance with Group Captive norms.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |